Mary Jane Masson

436 citations
10 papers · 308 indexed · h-index 9
    • Drug-Induced Hepatotoxicity and Protection 6
    • Drug-Induced Adverse Reactions 3
    • Pharmacological Effects of Natural Compounds 2
    • Pharmacogenetics and Drug Metabolism 2
  • Hepatology top 10%
    • Immune Cell Function and Interaction 4
    • T-cell and B-cell Immunology 2
    • Mast cells and histamine 1
    • Drug-Induced Hepatotoxicity and Protection 6
    • Drug-Induced Adverse Reactions 3
    • Pharmacological Effects of Natural Compounds 2
    • Pharmacogenetics and Drug Metabolism 2
    • Meta-analysis and systematic reviews 1

Mary Jane Masson

10 papers receiving 300 citations

Peers

Mary Jane Masson
Comparison fields: 5 of 70
  • Pharmacology 164
  • Hepatology 83
  • Immunology 79
  • Pharmacology 48
  • Virology 9
Replace Amy Sharma with:
Amy Sharma United States
Alpha Banks United States
M. Schmid Switzerland
Mathieu Porceddu France
Yongzheng Guo China
Sandra De Jonghe Belgium
Adrian Barnardo United Kingdom
Lay Ahyoung Lim Japan
Nigel Dallow United Kingdom
Orietta Staltari Italy
Mary Jane Masson relative to Amy Sharma United States Amy Sharma's profile →
Citations per field
00.5×3.2×
Amy Sharma · 1×
Citations per year

Countries citing papers authored by Mary Jane Masson

Since Specialization
Citations

This map shows the geographic impact of Mary Jane Masson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Jane Masson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Jane Masson more than expected).

Fields of papers citing papers by Mary Jane Masson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Jane Masson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Jane Masson. The network helps show where Mary Jane Masson may publish in the future.

Co-authorship network

The 17 scholars most cited alongside Mary Jane Masson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mary Jane Masson Line = papers co-authored together Mary Jane Masson links everyone, so they are left out of the graph.

All Works

10 of 10 papers shown
#Work
1 201021
2 200911
3 200888
4 200752
5 200620
6 200546
7 200419
8 200413
9 20046
10 200332

About Mary Jane Masson

Mary Jane Masson is a scholar working on Pharmacology, Immunology and Pharmacology, having authored 10 papers that have together received 308 indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (6 papers), Immune Cell Function and Interaction (4 papers), Drug-Induced Adverse Reactions (3 papers), Pharmacological Effects of Natural Compounds (2 papers), T-cell and B-cell Immunology (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Meta-analysis and systematic reviews (1 paper) and Mast cells and histamine (1 paper). The work is most often cited by research in Pharmacology (164 citations), Hepatology (83 citations) and Immunology (79 citations). Mary Jane Masson has collaborated with scholars based in Canada, United States and Russia. Frequent co-authors include Lance R. Pohl, Jack Uetrecht, Mary L. Graf, Mohammed Bourdi, Steven B. Yee, Jacintha Shenton, Marija Popović, Jie Chen, Thomas R. Einarson and M. Hemels. Their work appears in journals such as Hepatology, Biochemical and Biophysical Research Communications and Chemical Research in Toxicology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026